No to Negative Data

Why I believe findings that disprove a hypothesis are largely not worth publishing.

Written bySteven Wiley
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

A frequent criticism in biology is that we don't publish our negative data. As a result, the literature has become biased towards papers that favor specific hypotheses (Nature, 422:554—5, 2003). Some scientists have become so concerned about this trend that they have created journals dedicated to publishing negative results (e.g., Journal of Negative Results in Biomedicine). Personally, I don't think they should bother.

I say this because I believe negative results are not worth publishing. Rest assured that I do not include drug studies that show a lack of effectiveness towards a specific disease or condition. This type of finding is significant in a societal context, not a scientific one, and we all have a vested interest in seeing this type of result published. I am talking about a set of experimental results that fail to support a particular hypothesis. The problem with these types of negative results is that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies